Cardiac Assist Devices Market Surpasses US$ 1 Bn Mark in 2018
In recent years, emergence of mechanical assist therapy from a dream to tangible reality has ushered in a new era of cardiovascular medicine in which a growing number of devices exist to treat end stage heart failure. Cardiac assist devices in particular are gaining increasing momentum in clinical management of cardiovascular diseases (CVDs) in parallel with significant advances in device design. The market hit its US$ 1 Bn mark in 2018, and is expected to grow on significant pace over the next decade.
Frequently asked questions about global cardiac assist devices market
What are the major factors driving the growth of cardiac assist devices market?
The growth of the market is driven by increasing focus on the growing demand for efficient cardiac assist devices in developed countries, along with an increase in prevalence of heart failure.
Which technology is expected to disrupt the demand for cardiac assist devices?
The healthcare industry is beginning to evaluate the Internet of things (IoT) connected with wearable devices ultimately drive reduction in heart-related fatalities, and equip physicians and patients with the data they need to better manage heart problems post-diagnosis.
Where will the most profitable opportunities lie?
North America will continue to lead its way in the cardiac assist market, as local players and hospitals are undergoing collaborations to provide high-quality heart transplant services, ultimately supporting the growth of the market.
What are the dynamics catapulting the growth of cardiac assist devices market in Asia Pacific?
Continuous technological development in China and a large pool of cardiovascular disease patients traveling to India on a medical visa to seek cost-effective treatment are the major factors driving the growth of the market. Demand for cardiac assist devices is growing at a CAGR of 6.7% over the forecast period in Asia Pacific (excluding Japan).
What are the challenges limiting long-term growth of cardiac assist devices market?
Risk factors associated with these devices and a high price point associated with the treatment would remain major restraints impacting market growth. Several companies have incurred heavy financial losses due to several reported adverse events wherein the governments have issued warning letters.
Ventricular Assist Devices Remain Bestselling Category
Accounting for over 60% of the total revenue share, ventricular assist devices continue to stay in demand against intra-aortic balloon pumps. Increasing demand for left ventricular assist devices (LVADs) for excellent outcomes when compared to medical therapy is also significantly contributing to growth of this category. Moreover, ventricular assist devices will continue to be the product of choice in the future, as engineers and clinicians are envisioning the next-generation of devices that would be fully implantable on both left and right sides of the heart and adaptable to the unique physiologic demands of each patient.
North America at Forefront, Opportunities Abound in APEJ
North America continues to offer greater opportunities, with an army of digital health technologies joining the forces of conventional clinical tools in cardiology. Established reimbursement policies and growing frequency of innovation in medical devices in the region are working to the advantage of market players. Market consolidation in Asian Pacific countries, especially China and India, will remain a key to gaining distinct competitive edge, given consideration to significant advancements in healthcare space and growing government spending on advanced medical technologies to improve survival and overall quality of life in patients with advanced heart failure.
Minimally Invasive Device Insertion Techniques in Demand
Amidst robots finding their way into operating rooms, greater emphasis has been put on minimally invasive surgical intervention, thereby driving innovation in the cardiac assist devices. In recent years, emergence of state-of-the-art healthcare technologies has fueled the uptake of minimally invasive surgery for faster and better outcomes. Market players are the major step forward by creating smaller centrifugal pump of these devices that allow less-invasive implantation procedure. A shift from on-pump to off-pump cardiac assist device placement is further likely to bringing significant in device design, surgical techniques, and post-operative management of several cardiovascular diseases.
Ventricular assist devices account for the highest revenue
Demand for intra-aortic balloon pumps to grow at moderate rate
Implantable remains treatment modality of choice
Transcutaneous method to witness increasing demand
Surging adoption in hospital pharmacies
Demand from ambulatory surgical centers to pick pace
How Growth will Unfold
Adoption of cardiac assist devices by hospital pharmacies, especially in North America and Western Europe, is expected to remain strong going forward. Whereas, growing application in ambulatory surgical centers (ASCs) in Asia Pacific and Middle East & Africa is expected to result in increased market share. An ever-increasing percentage of total surgical procedures occurring in free-standing ASCs, in the view of faster outcomes with fewer patients requiring hospitalization, has been influencing market players to capitalize on these end users. However, it is pertinent to note that several risks associated with cardiac assist devices, such as pump thrombus, infections, and suction events are representing a potential threat for the market players.
* This data is only a representation. Actual data may vary and will be available in report.
Click Here To Know How The Growth Will UnfoldCustom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Overview
Cardiac Assist Devices Market Analysis 2019-2029
A recent market study published by Future Market Insights (FMI) on the cardiac assist devices including global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the cardiac assist devices market, growth prospects are obtained with maximum precision.
Cardiac Assist Devices Market Taxonomy
The global cardiac assist devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Product
- Ventricular Assist Device (VAD)
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular assist device (BIVAD)
- External Ventricular Assist Devices
- Intra-aortic Balloon Pump
Modality
- Transcutaneous
- Implantable
End User
- Hospital
- Ambulatory Surgical Centers
Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan (APEJ)
- Japan
- Middle East & Africa
What's Included
The report initiates with the executive summary of the cardiac assist devices market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the cardiac assist devices market.
Readers can find the definition and a detailed segmentation of the cardiac assist devices market in this chapter, which will help them understand the basic information about the market.
This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the cardiac assist devices market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
This section includes premium insights such as cardiovascular diseases outlook by country, health expenditure by country, technology evolution. This section helps readers understand the key factors associated with the cardiac assist devices market.
This section explains the global market value analysis and forecast for the cardiac assist devices during the forecast period. This chapter includes a detailed analysis of the historical cardiac assist devices market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).
Based on product, the cardiac assist devices market is segmented into Ventricular Assist Devices (VAD). VAD is further sub segmented into Left ventricular assist device (LVAD), right ventricular assist device (RVAD), Biventricular Assist Device (BIVAD), and external ventricular assist devices. The second segment is intra-aortic balloon pump. In this chapter, readers can find information about the key trends and developments in the cardiac assist devices and market attractiveness analysis based on product type.
This chapter provides details about the cardiac assist devices based on modality, and has been classified into transcutaneous and implantable. In this chapter, readers can understand the market attractiveness analysis based on modality.
This chapter provides details about the cardiac assist devices market based on end user, and has been classified into hospitals and ambulatory surgical centers. In this chapter, readers can understand the market attractiveness analysis based on end user.
This chapter explains how the cardiac assist devices market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America cardiac assist devices market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.
This chapter provides the growth scenario of the cardiac assist devices market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
This chapter provides the growth scenario of the cardiac assist devices market in Western Europe in several countries such as Germany, the U.K., France, Spain, Italy, NORDIC Countries, and the Rest of Europe are included in this chapter.
This chapter provides the growth scenario of the cardiac assist devices market in Eastern Europe in several countries such as Russia, Poland and the Rest of Eastern Europe are included in this chapter.
This chapter highlights the growth of the cardiac assist devices in Asia Pacific excluding Japan by focusing on China, India, Australia and New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the cardiac assist devices market in APEJ.
This chapter highlights the growth of the cardiac assist devices in Japan. This section also help readers understand the key factors that are responsible for the growth of the cardiac assist devices market in Japan.
This chapter provides information about how the cardiac assist devices market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period (2019-2029).
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the cardiac assist devices market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Medtronic PLC., Abbott Laboratories, Terumo Corporation, and among others.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the cardiac assist devices report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the cardiac assist devices.
How the research was conducted?
Primary Research
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
Secondary Research
- Associations
- American Heart Association (AHA)
- German Heart Institute
- European Society of Cardiology
- Factiva
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Primary Interview Splits
To Learn More About our Comprehensive Perspective on Cardiac Assist Devices Market,
Get in touch
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactOur Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.